US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

107.41

+0.61000.57%

Post-market: 108.150.7400+0.69%19:30 EDT

Volume:179.39K

Turnover:19.28M

Market Cap:1.75B

PE:10.00

High:107.94

Open:106.87

Low:106.87

Close:106.80

52wk High:108.66

52wk Low:69.02

Shares:16.30M

Float Shares:16.30M

Volume Ratio:0.76

T/O Rate:1.10%

Dividend:1.46

Dividend Rate:1.36%

EPS(TTM):10.74

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?

Heart Drug Developer Atrium Therapeutics' Q2 Loss Widens as Expenses Rise

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus for Relapsed Multiple Myeloma Combo Use

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First Celmod Therapy Zenbexus™, in Combination with Daratumumab and Hyaluronidase-Fihj and Dexamethasone (Zdd) for Patients with Multiple Myeloma, as Early as First Relapse

THOMSON REUTERS

Bristol-Myers Squibb - Zenbexus Available Only Through Restricted Zenbexus Rems Program

THOMSON REUTERS

Maze Therapeutics Adds Paula Johnson, Sophie Kornowski to Board

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

US FDA Approves Bristol Myers' Blood Cancer Treatment

FDA Grants Accelerated Approval to Iberdomide with Daratumumab and Hyaluronidase-Fihj and Dexamethasone for Multiple Myeloma

THOMSON REUTERS

Aktis Oncology Q2 FY26 Net Loss Widens 33.15% to $24.1 Million

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

Cytokinetics - Files Complaint Against Bristol-Myers Squibb and Myokardia - SEC Filing

THOMSON REUTERS

Cytokinetics - Demands Trial by Jury on All Triable Issues - SEC Filing

THOMSON REUTERS

Cytokinetics Sues Bristol Myers, MyoKardia Seeking Ruling on Myqorzo Patent Dispute

HCA’s Sarah Cannon Research Institute Partners with Merck to Expand Access to Oncology Clinical Trials in US Communities

Atrium Gets $15M in Latest Milestone Payment from Bristol Myers Squibb

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration

THOMSON REUTERS

Atrium Therapeutics - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties

THOMSON REUTERS

Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Development and Commercialization Activities

THOMSON REUTERS

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IHE/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IHE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","market":"US","secType":"STK","nameCN":"iShares U.S. Pharmaceuticals ETF","latestPrice":107.41,"timestamp":1787688000000,"preClose":106.8,"halted":0,"volume":179390,"hourTrading":{"tag":"盘后","latestPrice":108.15,"preClose":107.41,"latestTime":"19:30 EDT","volume":3017,"amount":326319.8562,"timestamp":1787700601896,"change":0.74,"changeRate":0.006889,"amplitude":0.008379},"delay":0,"changeRate":0.00571161048689138,"floatShares":16300000,"shares":16300000,"eps":10.735807,"marketStatus":"Closed","change":0.61,"latestTime":"08-25 16:00:00 EDT","open":106.87,"high":107.94,"low":106.87,"amount":19275060.842,"amplitude":0.010019,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":10.735807,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":106.8,"sharesOutstanding":11650000,"nav":106.743824,"aum":1755935904.8,"dividendRate":0.013621,"bidAskSpread":0.000956,"preHourTrading":{"tag":"盘前","latestPrice":107.42,"preClose":106.8,"latestTime":"09:02 EDT","volume":110,"amount":11756.03,"timestamp":1787662926890,"change":0.62,"changeRate":0.005805,"amplitude":0.008755},"postHourTrading":{"tag":"盘后","latestPrice":108.15,"preClose":107.41,"latestTime":"19:30 EDT","volume":3017,"amount":326319.8562,"timestamp":1787700601896,"change":0.74,"changeRate":0.006889,"amplitude":0.008379},"volumeRatio":0.761771,"impliedVol":0.1652,"impliedVolPercentile":0.9283},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","floatShares":16300000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.761771,"shares":16300000,"dividePrice":1.463,"high":107.94,"amplitude":0.010019,"preClose":106.8,"low":106.87,"week52Low":69.02,"pbRate":"--","week52High":108.66,"institutionHeld":0,"latestPrice":107.41,"eps":10.735807,"divideRate":0.013621,"volume":179390,"delay":0,"ttmEps":10.735807,"open":106.87,"prevYearClose":84.83,"prevWeekClose":106.79,"prevMonthClose":101.62,"prevQuarterClose":99.01,"fiveDayClose":105.31,"twentyDayClose":103.96,"sixtyDayClose":91.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IHE\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IHE","amount":0.284781,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IHE","amount":0.284491,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IHE","amount":0.585254,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IHE","amount":0.312397,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-06-16","symbol":"IHE","amount":0.306536,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IHE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.315888,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.33773,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.358233,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.91844,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.449501,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IHE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IHE\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659193520","title":"'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193520","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193520?lang=en_us&edition=fundamental","pubTime":"2026-08-14 06:00","pubTimestamp":1786658400,"startTime":"0","endTime":"0","summary":"They obviously do - enough to advertise heavily on TV. Yet, I didn't pay them a membership fee, and Walgreens was cooperative enough to put up large posters featuring their QR codes. I assume these programs get paid by pharmacy-benefit managers , but this medication was generic.The general rule of U.S. healthcare seems to be that everyone is making money except the patient .What exactly happened here?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820562030.AUD","LU1093756325.SGD","SG9999002232.USD","SGXZ31699556.SGD","LU0320765059.SGD","LU0058720904.USD","LU2087625088.SGD","LU0203201768.USD","LU0466842654.USD","BK4533","IE00B2B36J28.USD","LU1127390331.HKD","LU2265009873.SGD","LLII","LU1814569148.SGD","LU1069344957.HKD","LU0471298694.HKD","LU2552382058.USD","IYH","LU0122379950.USD","IE00BK4W5M84.HKD","FTXH","LU1721429402.USD","SG9999014880.SGD","SGXZ81514606.USD","LU0208291251.USD","LU2236285917.USD","IHE","SG9999017495.SGD","IE0004445015.USD","RXL","GDOC","SG9999015945.SGD","IE00B1XK9C88.USD","LU2023250330.USD","BK4516","LU2168563687.JPY","SG9999015978.USD","LU1720051017.SGD","SGXZ41872573.SGD","IE00BFSS7M15.SGD","LU2468319806.SGD","LU0114720955.EUR","LU2111349929.HKD","LU2746668461.USD","LU1974910355.USD","IE0001KFT4U8.USD","LU1868837300.USD","LU0672654240.SGD","LU2089284900.SGD","THNR","ILDR","IXJ","LU1720051108.HKD","PPH","LU0170899867.USD","LU0097036916.USD","LU1721429741.USD","WDNA","LU2491050154.USD","LU1061106388.HKD","LU0106261372.USD","LU0061475181.USD","IE00B7KXQ091.USD","LU2456880835.USD","LU0345770993.USD","LU0079474960.USD","LU1629891620.HKD","LU0820561909.HKD","BK4581","LU0823416689.USD","LU1145028129.USD","LU2237443549.SGD","LU0289739699.SGD","LU2756315318.SGD","BK4566","LU1280957306.USD","LU2168564149.EUR","LLY","LU0006306889.USD","LU2063271972.USD","LU2237443465.HKD","LU2237443895.HKD","MEDX","IE00BN29S564.USD","LU2089984988.USD","SG9999013999.USD","LU2133065610.SGD","SGXZ23171101.USD","LU2361044949.HKD","LU2896262040.SGD","LU0708995401.HKD","OZEM","LU0943347566.SGD","LU1917777945.USD","LU0174119429.USD","LU1023059063.AUD","LU2357305700.SGD","LU0109394709.USD","LU2462157665.USD","IE00BFSS8Q28.SGD","IE00BJJMRY28.SGD","SG9999014914.USD","LU2237443978.SGD","IE00BK4W5L77.USD","IE0002141913.USD","LU0094547139.USD","LU2237957811.SGD","IE0009355771.USD","LU2213496289.HKD","LU1267930730.SGD","LU1868836757.USD","LU2168564495.EUR","LU1804176565.USD","IE00B4JS1V06.HKD","LU0787776722.HKD","BK4007","LU2237957902.USD","LU2491050071.SGD","SG9999001176.SGD","LU1691799644.USD","LU2271345857.HKD","LU1989763427.SGD","LU0964807845.USD","VHT","LU0158827948.USD","LU0820561818.USD","LU2461242641.AUD","LU2417539215.USD","GB00BDT5M118.USD","LU2552382215.SGD","LU1623119135.USD","LU0198837287.USD","LU1548497426.USD","TRUH","LU0432979614.USD","IE00B775H168.HKD","LU2237443382.USD","LU2471134523.USD","LU2471134879.HKD","BK4534","LU1989763690.USD","LU0256863902.USD","LU2089283258.USD","LU2106854487.HKD","TMED","SG9999001176.USD","LU2112291526.USD","CURE","BK4585","LU0109391861.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU0456855351.SGD","SGXZ99366536.SGD","LU1232071149.USD","BK4504","BK4568","IE0004445239.USD","LU0096364046.USD","LU2491049909.HKD","LU0256863811.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","JDOC","LU0471298777.SGD","ELIL","LU2361045086.USD","LU0320765992.SGD","LU2023250504.SGD","LU1988902786.USD","LU0225283273.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU0385154629.USD","LU1551013342.USD","LU2750360641.GBP","BK4588","IE00BJJMRX11.SGD","LU0889565916.HKD","LU0203202063.USD","LU2237438978.USD","HRTS","LU0882574139.USD","LU2324357040.USD","SG9999014898.SGD","LU1064131342.USD","LU2471134796.USD","MEDI","SG9999004303.SGD","LU2756315664.SGD","LU2462591350.SGD","IE00BWXC8680.SGD","LU0353189680.USD","LLYZ","SGXZ51526630.SGD","IHI","LU0316494557.USD","LU2168564222.USD","LU0354030511.USD","LU1712237335.SGD","SG9999002224.SGD","LU0823434740.USD","LU0133085943.USD","LU0689472784.USD","LU1868836914.USD","LU2028103732.USD","XLV","CANC","LU0320765489.SGD","LU0158827781.USD","LU2750360997.AUD","IE0005OL40V9.USD","BK4082","LU0354030438.USD","LU2552382132.HKD","PJP","SG9999018857.SGD","LLYX","FHLC","LU1868836591.USD","BK4599","LU2211815571.USD","LU2237443622.USD","LU2360106947.USD","MHIP","LU2361044865.SGD","SG9999015986.USD","LU1989771016.USD","SG9999018865.SGD","SG9999015952.SGD","LU2023251221.USD","SGXZ57979304.SGD","AGNG","LU0234572021.USD","LU2602419157.SGD","ELIS","BK4167","LU1551013425.SGD","SG9999014906.USD","IE00BKDWB100.SGD","LU0345770308.USD","LU0683600562.USD","LU0353189763.USD","LU0823434583.USD","IE00BKPKM429.USD","LU1057294990.SGD","LU1291159041.SGD","LU1323610961.USD","LU1868837136.USD","LU1914381329.SGD","LU1979441026.SGD","LU2108987350.USD","LU2746668974.SGD","LU0882574055.USD","LU0070302665.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0211331839.USD","LU2471134952.CNY","BK4592","LU0266013472.USD","IE00BJLML261.HKD","LU1093756168.USD","LU0417517546.SGD","LU0238689110.USD","GDRX","LU0323591593.USD","LU1366192091.USD","LU0640476718.USD","LU1983299246.USD","ABT","LU2264538146.SGD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659193899","title":"Heart Drug Developer Atrium Therapeutics' Q2 Loss Widens as Expenses Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193899","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193899?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:46","pubTimestamp":1786657566,"startTime":"0","endTime":"0","summary":"Heart drug developer Atrium Therapeutics' Q2 loss widens as expenses riseOverviewU.S. biopharmaceutical firm's Q2 collaboration revenue fell yr/yr as R&D services declinedCompany posted wider net loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A1BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2596442595.SGD","IE00BFXG1179.USD","LU1989771016.USD","IE0009354923.USD","LU1868836591.USD","LU1868837300.USD","IE0002141913.USD","BK4534","LU1718418525.SGD","BMY","LU1670710588.SGD","LU1430594728.SGD","LU2242652126.USD","LU1670710661.SGD","LU0432979614.USD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","IE00BJT1NW94.SGD","LU1868836914.USD","LU1074936037.SGD","LU0882574055.USD","BK4007","LU1032466523.USD","LU1291159041.SGD","LU1983299246.USD","ENSC","BK4585","LU1093756168.USD","KOD","RNA","FTXH","IHE","BK4505","LU0985481810.HKD","LU1868836757.USD","LU0868494617.USD","LU0237698245.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1883839398.USD","LU0456855351.SGD","LU0225284248.USD","LU0306806265.USD","IE00B2B36J28.USD","BK4532","LU1093756325.SGD","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659198356","title":"FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus for Relapsed Multiple Myeloma Combo Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2659198356","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659198356?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:12","pubTimestamp":1786655562,"startTime":"0","endTime":"0","summary":"FDA grants accelerated approval to Bristol Myers Squibb’s ZENBEXUS for relapsed multiple myeloma combo useFDA granted accelerated approval to Bristol Myers Squibb’s ZENBEXUS (iberdomide) with daratumu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbw8PFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU1093756168.USD","LU0882574055.USD","BK4588","LU0061475181.USD","LU1868837300.USD","LU1585245621.USD","LU0237698245.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU2242646821.SGD","LU1983299246.USD","LU1989771016.USD","BMY","LU1670710588.SGD","LU1868837136.USD","LU1323610961.USD","LU1093756325.SGD","LU1571399168.USD","LU0306806265.USD","LU2125154778.USD","LU1032466523.USD","IE00B2B36J28.USD","BK4534","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1670711123.USD","LU2242652126.USD","LU2133065610.SGD","LU0321505868.SGD","LU1670711040.USD","BK4559","BK4585","FTXH","LU0225284248.USD","LU1868836591.USD","LU1430594728.SGD","IHE","LU1074936037.SGD","BK4581","BK4532","LU1883839398.USD","LU2125154935.USD","IE0009355771.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU1670710661.SGD","LU0432979614.USD","LU1291159041.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659337198","title":"U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First Celmod Therapy Zenbexus™, in Combination with Daratumumab and Hyaluronidase-Fihj and Dexamethasone (Zdd) for Patients with Multiple Myeloma, as Early as First Relapse","url":"https://stock-news.laohu8.com/highlight/detail?id=2659337198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659337198?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:12","pubTimestamp":1786655520,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUACR6JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","LU1074936037.SGD","LU0096364046.USD","LU1032466523.USD","LU2242652126.USD","BK4532","LU2125154935.USD","BK4007","LU2242646821.SGD","LU0061475181.USD","LU1430594728.SGD","LU0306806265.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU2596442595.SGD","LU0882574055.USD","LU0868494617.USD","LU1670710661.SGD","LU1670711040.USD","BK4585","LU0321505439.SGD","LU1868837136.USD","LU2125154778.USD","LU0432979614.USD","LU1868836757.USD","LU0237698245.USD","BMY","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU1093756325.SGD","LU0321505868.SGD","IHE","BK4588","LU1868837300.USD","LU0225771236.USD","LU0306807586.USD","LU1989771016.USD","BK4534","LU2360032135.SGD","LU1670710588.SGD","LU1868836914.USD","LU0985481810.HKD","LU1261432733.SGD","LU0225284248.USD","IE00BFXG1179.USD","BK4581","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659198332","title":"Bristol-Myers Squibb - Zenbexus Available Only Through Restricted Zenbexus Rems Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659198332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659198332?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:12","pubTimestamp":1786655520,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUACR6JL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1585245621.USD","LU2596442595.SGD","LU2125154935.USD","LU0114720955.EUR","LU1989771016.USD","LU1868836591.USD","LU1868837300.USD","LU0061475181.USD","LU1670711040.USD","IE0002141913.USD","BK4534","LU1718418525.SGD","LU2360032135.SGD","BMY","LU1670710588.SGD","LU2133065610.SGD","LU1430594728.SGD","LU1670710661.SGD","LU0432979614.USD","LU0321505439.SGD","LU2125154778.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU1868836914.USD","LU1074936037.SGD","LU0882574055.USD","LU1291159041.SGD","LU1868837136.USD","LU1983299246.USD","LU0321505868.SGD","IHE","FTXH","LU0225771236.USD","BK4581","IE0009355771.USD","BK4532","LU0237698245.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1883839398.USD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU0225284248.USD","IE00B2B36J28.USD","LU0096364046.USD","LU2242652126.USD","BK4588","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614160","title":"Maze Therapeutics Adds Paula Johnson, Sophie Kornowski to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614160","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659614160?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:49","pubTimestamp":1786654155,"startTime":"0","endTime":"0","summary":"Maze Therapeutics adds Paula Johnson, Sophie Kornowski to boardMaze Therapeutics appointed Paula Johnson and Sophie Kornowski to its board.Johnson is president of Wellesley College, a cardiologist, an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL7LTtBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU2456880835.USD","BMED","IE00BJT1NW94.SGD","BCDF","MAZE","LU0820561818.USD","BK4534","LU0689626769.HKD","LU1778281490.HKD","MEDX","LU0787776722.HKD","SGXZ80539844.SGD","IHE","IE000SO60NU8.SGD","LU1244550494.USD","LU0820561909.HKD","IE00BKPKM429.USD","LU0985320562.USD","LU1732800096.USD","IXJ","IE00BGHQF631.EUR","LU1043141123.HKD","LU1894683348.USD","JNJ","LU2112291526.USD","IE00BZ1G4Q59.USD","IE00BVYPNW00.USD","LU0345769128.USD","FHLC","LU0320765646.SGD","LU2471134523.USD","IYH","GDOC","FTXH","LU0689472784.USD","LU2129689431.USD","BK4585","JDOC","TRUH","XLV","LU1066051811.HKD","LU0345770993.USD","PJP","NDAQ","LU0964807845.USD","LU0820562030.AUD","RXL","LU1221951046.USD","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659670301","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2659670301","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659670301?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:37","pubTimestamp":1786653420,"startTime":"0","endTime":"0","summary":"DJ Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  advanced 1.49% to $64.65 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.65% to 7,798.99 and the Dow Jones Industrial Average  rising 0.13% to 53,839.99.This was the stock's second consecutive day of gains.Bristol Myers Squibb Co. closed 5.07% below its 52-week high of $68.10, which the company reached on August 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.47% to $262.08, Pfizer Inc.  rose 1.86% to $26.80, and Abbott Laboratories  rose 0.32% to $111.27.Trading volume  remained 2.1 million below its 50-day average volume of 12.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU2133065610.SGD","LU1093756325.SGD","LU1718418525.SGD","LU1670711040.USD","LU2242652126.USD","LU2242646821.SGD","BK4007","LU1571399168.USD","BK4534","IE0002141913.USD","LU1868836591.USD","BK4581","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU0096364046.USD","IE00BSNM7G36.USD","LU1093756168.USD","LU1989771016.USD","LU1323610961.USD","LU2596442595.SGD","BK4559","LU0321505439.SGD","LU2360032135.SGD","LU1670710588.SGD","BK4585","LU0225771236.USD","LU0237698245.USD","LU1032466523.USD","LU1868837300.USD","LU0868494617.USD","LU1074936037.SGD","LU1430594728.SGD","LU2125154778.USD","LU1883839398.USD","LU1868836914.USD","LU1868837136.USD","LU1291159041.SGD","LU2125154935.USD","IE00BFXG1179.USD","IHE","LU0306807586.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BMY","FTXH","LU0456855351.SGD","LU0114720955.EUR","LU1670710661.SGD","IE00BJT1NW94.SGD","LU0267386448.USD","LU0225284248.USD","LU1670711123.USD","LU1585245621.USD","LU0321505868.SGD","LU1983299246.USD","BK4532","LU0061475181.USD","LU0882574055.USD","LU1868836757.USD","LU1261432733.SGD","LU0432979614.USD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162072","title":"US FDA Approves Bristol Myers' Blood Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162072","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162072?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652128,"startTime":"0","endTime":"0","summary":"US FDA approves Bristol Myers' blood cancer treatmentAug 13 (Reuters)-The U.S.FDAon Thursday approved Bristol Myers Squibb'sBMY.Ncombination treatmentforpatients with a rare form of blood cancer whose illness had relapsed or not responded to other treatments, the health regulator said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A1MY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","BK4534","TRUH","LU2112291526.USD","LU0320765646.SGD","BMY","LU2596442595.SGD","IE00BGHQF631.EUR","IXJ","IE000SO60NU8.SGD","LU0820562030.AUD","LU0820561818.USD","LU1894683348.USD","PJP","LU1221951046.USD","LU0985320562.USD","JNJ","LU1732800096.USD","LU1093756168.USD","LU0820561909.HKD","IE00BSNM7G36.USD","VHT","LU0689472784.USD","LU1066051811.HKD","RXL","BK4585","LU0345770993.USD","LU1244550494.USD","LU2456880835.USD","LU2360032135.SGD","GDOC","FTXH","IE00BVYPNW00.USD","LU2471134523.USD","LU2129689431.USD","LU0096364046.USD","LU0345769128.USD","XLV","FHLC","IHE","LU0787776722.HKD","LU0689626769.HKD","LU1778281490.HKD","BMED","LU1043141123.HKD","IE00BZ1G4Q59.USD","MEDX","LU0964807845.USD","JDOC","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162424","title":"FDA Grants Accelerated Approval to Iberdomide with Daratumumab and Hyaluronidase-Fihj and Dexamethasone for Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162424?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:11","pubTimestamp":1786651886,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","IHE","LU1585245621.USD","LU1093756325.SGD","LU2125154778.USD","LU0225771236.USD","IE0009355771.USD","LU0456855351.SGD","LU0225284248.USD","LU1670710588.SGD","LU0114720955.EUR","LU1323610961.USD","FTXH","IE00BSNM7G36.USD","BK4581","BK4585","LU1868836591.USD","LU1291159041.SGD","LU1883839398.USD","LU1430594728.SGD","LU1093756168.USD","LU0321505868.SGD","BK4588","LU1074936037.SGD","BK4532","LU0868494617.USD","LU0096364046.USD","LU2242652126.USD","LU1571399168.USD","BMY","IE00BFXG1179.USD","LU1670711040.USD","LU0267386448.USD","LU0306807586.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1868836757.USD","LU2125154935.USD","LU1983299246.USD","LU0306806265.USD","LU2360032135.SGD","LU0237698245.USD","LU1989771016.USD","LU1868837136.USD","LU1718418525.SGD","LU0985481810.HKD","BK4559","BK4007","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162577","title":"Aktis Oncology Q2 FY26 Net Loss Widens 33.15% to $24.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162577","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162577?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651516,"startTime":"0","endTime":"0","summary":"Aktis Oncology Q2 FY26 net loss widens 33.15% to $24.1 millionAktis Oncology posted a net loss of $24.1 million for Q2 2026, widening from $18.1 million a year earlier.Collaboration revenue rose 112.5","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1RsypG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069344957.HKD","LU0345770308.USD","LU2361044949.HKD","LU1804176565.USD","LU2237438978.USD","LU0820562030.AUD","LU2237443382.USD","LU2357305700.SGD","LU2491049909.HKD","BK4533","LU1145028129.USD","ELIL","WDNA","LU2746668974.SGD","IE00B1XK9C88.USD","LU2168564149.EUR","AKTS","LLYX","IE00B1BXHZ80.USD","LU0882574055.USD","LU1720051108.HKD","LU2456880835.USD","LU0672654240.SGD","IE00BK4W5L77.USD","LU0823416689.USD","LU0385154629.USD","SGXZ81514606.USD","LU1057294990.SGD","LU0353189763.USD","LU1868837136.USD","LU1551013342.USD","LU1712237335.SGD","LU2213496289.HKD","LU2087625088.SGD","LU2471134952.CNY","LU2324357040.USD","LU1232071149.USD","IYH","LU0354030438.USD","LU0256863811.USD","LU1093756325.SGD","PJP","IHE","SGXZ51526630.SGD","LU1989771016.USD","OZEM","LU2462157665.USD","LU2237443895.HKD","LU2756315664.SGD","LU0345770993.USD","JDOC","IE00BKDWB100.SGD","LU0158827948.USD","LU2237443549.SGD","IE00BK4W5M84.HKD","LU2361045086.USD","LU0094547139.USD","LU1974910355.USD","VHT","THNR","FHLC","LU0889565916.HKD","LU0096364046.USD","LU1548497426.USD","LU1983299246.USD","SG9999001176.SGD","CANC","LU2896262040.SGD","GDOC","LU0122379950.USD","LU2168564222.USD","LU2491050154.USD","XLV","LU0061475181.USD","IE00BJJMRY28.SGD","ILDR","LU0353189680.USD","LU2237443622.USD","LU2461242641.AUD","LU2360106947.USD","LU1917777945.USD","LU0456855351.SGD","LU0006306889.USD","SG9999014898.SGD","IE00BFSS7M15.SGD","MHIP","BK4585","LU2111349929.HKD","LU0432979614.USD","LU1291159041.SGD","BK4139","RXL","LU2602419157.SGD","IE0001KFT4U8.USD","LU0354030511.USD","SG9999018857.SGD","LU0316494557.USD","IE00B4JS1V06.HKD","IE00BFSS8Q28.SGD","LU2361044865.SGD","LU2462591350.SGD","LU0289739699.SGD","SGXZ31699556.SGD","LU0683600562.USD","LU2471134796.USD","IE00BJJMRX11.SGD","LU2089284900.SGD","BK4148","LU0109394709.USD","IE00BN29S564.USD","LU0471298694.HKD","BK4599","LU0320765059.SGD","LU0466842654.USD","SGXZ99366536.SGD","SG9999015952.SGD","LU0198837287.USD","LU2023251221.USD","PPH","BK4581","FTXH","IE00BJT1NW94.SGD","LU2417539215.USD","LU2746668461.USD","LU0133085943.USD","LU0266013472.USD","LU2491050071.SGD","LU0210536198.USD","LU0256863902.USD","LU0158827781.USD","LU1280957306.USD","LU2271345857.HKD","LU0689472784.USD","LU1720051017.SGD","SG9999014880.SGD","LU0238689110.USD","SG9999015978.USD","LU2237443465.HKD","LU0708995401.HKD","LU0943347566.SGD","LU1868836757.USD","LU0114720955.EUR","LU0106261372.USD","LU0471298777.SGD","SG9999015986.USD","IXJ","HRTS","LU1267930730.SGD","LU2236285917.USD","LU0203202063.USD","LU2089984988.USD","LLY","IE00B775H168.HKD","IE00BFTCPJ56.SGD","LU2108987350.USD","LU0058720904.USD","SG9999018865.SGD","LU2468319806.SGD","LU2750360997.AUD","LU1988902786.USD","BK4534","LU0882574139.USD","LU2023250330.USD","LU0820561909.HKD","LU2168563687.JPY","LU2063271972.USD","LU2471134879.HKD","LU0823434740.USD","LU2756315318.SGD","IE0004445239.USD","LU0225283273.USD","LU2471134523.USD","LU0174119429.USD","LU0786609619.USD","TMED","SG9999014906.USD","LU0079474960.USD","LU2106854487.HKD","IE0009355771.USD","MEDI","LU2211815571.USD","GB00BDT5M118.USD","LU1035775433.USD","LU1979441026.SGD","LU1061106388.HKD","LU2028103732.USD","LU0320765992.SGD","SG9999013999.USD","BK4007","SG9999015945.SGD","IE00B7KXQ091.USD","SGXZ57979304.SGD","LU2265009873.SGD","LU0640476718.USD","LU2552382132.HKD","LU2023250504.SGD","LU2168564495.EUR","LU2089283258.USD","LU1064131342.USD","IE00BKPKM429.USD","IE0002141913.USD","LU1323610961.USD","IE00BJJMRZ35.SGD","LU0203201768.USD","ELIS","LU2168564065.EUR","LU2237443978.SGD","LU2264538146.SGD","SG9999017495.SGD","AGNG","IE00BJLML261.HKD","LU1366192091.USD","LU2112291526.USD","TRUH","LU0109391861.USD","SG9999001176.USD","LU0323591593.USD","LLII","IE0004445015.USD","LLYZ","LU0787776722.HKD","LU2750360641.GBP","LU2552382058.USD","LU1814569148.SGD","LU0097036916.USD","CURE","IE00B2B36J28.USD","LU1623119135.USD","IE00B4R5TH58.HKD","IE00BWXC8680.SGD","LU0234572021.USD","LU0417517546.SGD","BK4516","LU1868836591.USD","BK4588","LU1093756168.USD","LU1127390331.HKD","LU1868837300.USD","LU1551013425.SGD","LU2552382215.SGD","LU1868836914.USD","MEDX","LU0964807845.USD","SG9999014914.USD","IE0005OL40V9.USD","LU0820561818.USD","LU1023059063.AUD","LU1629891620.HKD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165833","title":"Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165833","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165833?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:52","pubTimestamp":1786632731,"startTime":"0","endTime":"0","summary":"The legal battle has erupted as competition between the companies intensifies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-ceo-defends-lawsuit-against-eli-lilly-lly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-ceo-defends-lawsuit-against-eli-lilly-lly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999014914.USD","LU2089283258.USD","SG9999014880.SGD","IE0001KFT4U8.USD","BK4534","IE00B2B36J28.USD","LU0823434583.USD","LU2360106947.USD","LU1551013425.SGD","LU2106854487.HKD","LU1712237335.SGD","SG9999001176.USD","ILDR","LU2168564065.EUR","IE00BKDWB100.SGD","LLYZ","LU2237443549.SGD","LU2237443622.USD","LU2237443895.HKD","LU2265009873.SGD","LU2271345857.HKD","MEDI","LU0353189680.USD","LU0823434740.USD","LU0820561818.USD","LU2237438978.USD","ELIL","IE00BN29S564.USD","LLY","IE00B7KXQ091.USD","LU1232071149.USD","LU0683600562.USD","LU2237443978.SGD","LU0154236417.USD","LU0256863902.USD","LU0823416689.USD","LU0203201768.USD","BK4599","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2361044865.SGD","LU0323591593.USD","IE00BKVL7J92.USD","LU0889565916.HKD","LU1548497426.USD","SG9999013999.USD","LU1623119135.USD","LU1979441026.SGD","GB00BDT5M118.USD","SG9999018865.SGD","LU0109394709.USD","LU0466842654.USD","LU2750360997.AUD","LU2087625088.SGD","AGNG","CURE","LU0097036916.USD","LU0006306889.USD","LU0432979614.USD","LU1127390331.HKD","SGXZ81514606.USD","LU2023250504.SGD","BK4581","LU0354030511.USD","LU1291159041.SGD","LU2089984988.USD","LLII","LU0133085943.USD","LU0786609619.USD","BK4532","LU0238689110.USD","IE0005OL40V9.USD","LU2168564222.USD","IE00BK4W5M84.HKD","LU2112291526.USD","LU0158827781.USD","LU2264538146.SGD","LU0316494557.USD","LU2324357040.USD","LU0096364046.USD","LU1868837300.USD","SGXZ31699556.SGD","SGXZ51526630.SGD","LU2168563687.JPY","IE00B1BXHZ80.USD","LLYX","IE00BFTCPJ56.SGD","LU1868837136.USD","SG9999015952.SGD","LU0672654240.SGD","IE00B4JS1V06.HKD","LU1974910355.USD","BK4516","LU2361044949.HKD","LU2168564495.EUR","IE00BK4W5L77.USD","LU2237443382.USD","LU2237443465.HKD","MHIP","LU2468319806.SGD","LU0345770308.USD","LU2417539215.USD","LU2896262040.SGD","NVOH","LU0114720955.EUR","IE00BKPKM429.USD","LU1145028129.USD","LU2236285917.USD","LU0256863811.USD","ELIS","LU1057294990.SGD","LU2213496289.HKD","CANC","LU1093756168.USD","LU2491049909.HKD","LU2023251221.USD","LU1917777945.USD","LU2750360641.GBP","VHT","WDNA","LU1720051108.HKD","LU2491050071.SGD","LU1280957306.USD","LU2552382215.SGD","LU1035775433.USD","LU2108987350.USD","LU2462157665.USD","LU0820562030.AUD","LU0094547139.USD","LU1267930730.SGD","LU0471298694.HKD","LU1023059063.AUD","IXJ","LU0689472784.USD","PJP","LU2471134796.USD","LU0345770993.USD","LU2089284900.SGD","IE00B775H168.HKD","LU2028103732.USD","BK4588","LU2471134952.CNY","LU1069344957.HKD","LU0943347566.SGD","IE00BFSS7M15.SGD","LU2602419157.SGD","NVOX","LU0158827948.USD","LU1868836591.USD","IE00BJJMRX11.SGD","LU1868836757.USD","RXL","LU2357305700.SGD","LU1093756325.SGD","LU1366192091.USD","LU2471134523.USD","FTXH","SG9999017495.SGD","LU0122379950.USD","TRUH","HRTS","LU2756315318.SGD","LU0882574139.USD","LU0289739699.SGD","SGXZ99366536.SGD","IE00B1XK9C88.USD","LU2063271972.USD","XLV","THNR","BK4007","LU1629891620.HKD","LU0820561909.HKD","SG9999015986.USD","IE00BZ1G4Q59.USD","IE00BWXC8680.SGD","LU0354030438.USD","LU0417517546.SGD","IE0004445239.USD","BK4533","IE00BFSS8Q28.SGD","LU0708995401.HKD","LU1720051017.SGD","LU2111349929.HKD","LU2361045086.USD","LU0456855351.SGD","LU1814569148.SGD","LU2023250330.USD","LU2211815571.USD","LU2746668974.SGD","JDOC","NVO","TMED","LU0787776722.HKD","IE0002141913.USD","LU2456880835.USD","LU2462591350.SGD","LU2461242641.AUD","IYH","LU0198837287.USD","LU2756315664.SGD","IE00BJJMRY28.SGD","LU1064131342.USD","FHLC","SG9999015978.USD","LU0106261372.USD","MEDX","IE00BJT1NW94.SGD","LU0882574055.USD","SG9999018857.SGD","IE00B4R5TH58.HKD","LU0061475181.USD","LU0058720904.USD","LU0640476718.USD","LU1868836914.USD","LU1804176565.USD","LU2168564149.EUR","IHE","LU2552382058.USD","LU2552382132.HKD","LU0385154629.USD","LU1988902786.USD","LU0353189763.USD","PPH","SGXZ57979304.SGD","LU0266013472.USD","LU0174119429.USD","LU0471298777.SGD","SG9999014898.SGD","IE0009355771.USD","LU1551013342.USD","LU0234572021.USD","GDOC","LU0964807845.USD","LU1061106388.HKD","LU0320765992.SGD","OZEM","LU1989771016.USD","LU0225283273.USD","SG9999014906.USD","LU2471134879.HKD","SG9999001176.SGD","IE00BJLML261.HKD","LU0320765059.SGD","LU2491050154.USD","IE0004445015.USD","LU1323610961.USD","LU0079474960.USD","LU2746668461.USD","SG9999015945.SGD","LU0203202063.USD","LU0210536198.USD","BK4585","LU0109391861.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659215702","title":"Cytokinetics - Files Complaint Against Bristol-Myers Squibb and Myokardia - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659215702","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659215702?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:26","pubTimestamp":1786627584,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1H7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","LU0096364046.USD","IE00B2B36J28.USD","LU0267386448.USD","LU0237698245.USD","LU1093756168.USD","LU2596442595.SGD","IE0002141913.USD","IHE","LU0225284248.USD","LU0432979614.USD","LU0306806265.USD","LU1323610961.USD","LU1670711040.USD","LU1883839398.USD","LU0868494617.USD","LU1093756325.SGD","LU1868837136.USD","IE0009355771.USD","BK4559","IE00BSNM7G36.USD","FTXH","IE00BFXG1179.USD","LU1983299246.USD","LU2242646821.SGD","LU1585245621.USD","LU1571399168.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1718418525.SGD","LU1074936037.SGD","LU0321505868.SGD","CYTK","LU1868836757.USD","BK4532","LU0114720955.EUR","LU1868836914.USD","LU0882574055.USD","LU0456855351.SGD","BK4585","LU0225771236.USD","BMY","IE00BFTCPJ56.SGD","LU1670711123.USD","LU0321505439.SGD","LU1670710661.SGD","BK4007","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157026","title":"Cytokinetics - Demands Trial by Jury on All Triable Issues - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157026","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157026?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:26","pubTimestamp":1786627584,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1H7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMY","LU0237698245.USD","LU1670711123.USD","LU0456855351.SGD","BK4505","FTXH","LU0306806265.USD","LU0321505439.SGD","LU0321505868.SGD","IE00BFXG1179.USD","IE00BJJMRZ35.SGD","LU1670711040.USD","LU1883839398.USD","LU1989771016.USD","IE00BSNM7G36.USD","IHE","BK4007","BK4559","LU0985481810.HKD","BK4585","LU1670710661.SGD","LU2133065610.SGD","BK4588","LU1718418525.SGD","LU0225771236.USD","IE00BJT1NW94.SGD","IE0002141913.USD","LU1983299246.USD","LU0306807586.USD","LU1670710588.SGD","LU1323610961.USD","LU2125154935.USD","IE0009355771.USD","LU0868494617.USD","BK4534","BK4139","LU1868836757.USD","LU2360032135.SGD","BK4532","LU1571399168.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0096364046.USD","LU0267386448.USD","CYTK","LU2242652126.USD","LU2596442595.SGD","LU1261432733.SGD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659071157","title":"Cytokinetics Sues Bristol Myers, MyoKardia Seeking Ruling on Myqorzo Patent Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2659071157","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659071157?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:26","pubTimestamp":1786627564,"startTime":"0","endTime":"0","summary":"Cytokinetics sues Bristol Myers, MyoKardia seeking ruling on MYQORZO patent disputeCytokinetics filed a complaint on Aug. 13, 2026 in U.S. District Court in Delaware against Bristol-Myers Squibb, MyoK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbSBzdX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1093756325.SGD","CYTK","LU2242646821.SGD","LU1670710588.SGD","LU1261432733.SGD","IE00B2B36J28.USD","LU1670711040.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1868836591.USD","FTXH","LU0096364046.USD","IHE","LU0868494617.USD","IE0002141913.USD","LU1670711123.USD","IE00BFXG1179.USD","LU1718418525.SGD","LU1670710661.SGD","LU1989771016.USD","LU2242652126.USD","LU1883839398.USD","IE00BSNM7G36.USD","LU0321505868.SGD","LU0114720955.EUR","BK4007","BK4588","LU1074936037.SGD","LU0267386448.USD","LU1032466523.USD","LU1868837300.USD","BMY","LU0225284248.USD","BK4139","LU0225771236.USD","LU1291159041.SGD","LU2125154778.USD","BK4532","LU0321505439.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0306807586.USD","LU1430594728.SGD","BK4581","LU1093756168.USD","LU0432979614.USD","LU1983299246.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659157344","title":"HCA’s Sarah Cannon Research Institute Partners with Merck to Expand Access to Oncology Clinical Trials in US Communities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659157344","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659157344?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:02","pubTimestamp":1786626155,"startTime":"0","endTime":"0","summary":"HCA’s Sarah Cannon Research Institute partners with Merck to expand access to oncology clinical trials in US communitiesHCA Healthcare’s Sarah Cannon Research Institute formed a strategic collaboratio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5C7ctk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU0310799852.SGD","LU1571399168.USD","BK4007","LU1934455863.HKD","LU1989772840.SGD","SG9999013999.USD","LU2361044865.SGD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU0980610538.SGD","LU2112291526.USD","LU0432979614.USD","LU1267930573.SGD","LU2491049909.HKD","LU0859254822.USD","LU1093756325.SGD","LU1923622614.USD","PAWZ","SGXZ57979304.SGD","LU1162221912.USD","FHLC","LU1934455194.USD","LU1430594728.SGD","IE00BBT3K403.USD","LU0124676726.USD","LU2125909247.SGD","SG9999001440.SGD","LU0965509283.SGD","LU2125909593.SGD","LU0265550359.USD","LU0187121727.USD","LU2089984988.USD","LU2125154935.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","SG9999014013.SGD","LU2355687059.USD","SG9999015341.SGD","LU0868494708.USD","BMED","MRK","LU0289739699.SGD","IE0009355771.USD","LU0098860793.USD","TRUH","LU1941712348.USD","LU1037948541.HKD","LU1267930490.SGD","LU1989771016.USD","SG9999002232.USD","LU0265550946.USD","LU2357627491.SGD","LU0882574055.USD","LU1489326972.SGD","LU2023250504.SGD","GDOC","IXJ","XLV","LU1699723380.USD","BK4588","LU0006306889.USD","LU0211331839.USD","LU0861579265.USD","RXL","LU2461242641.AUD","LU1941712264.USD","LU1150488135.SGD","LU0029864427.USD","IE00B3S45H60.SGD","LU0965508806.USD","LU1261432733.SGD","JDOC","BK4585","LU0477156953.USD","LU1066051225.USD","BK4516","LU1035773651.USD","LU0234572021.USD","SG9999015358.SGD","SG9999014567.USD","LU2361045086.USD","LU0211327993.USD","LU1066053197.SGD","LU1929549753.HKD","IE0002141913.USD","LU1150488218.USD","IE00BJJMRZ35.SGD","LU1934455277.USD","LU0878866978.SGD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU1119994496.HKD","LU2361044949.HKD","PPH","LU0965509010.AUD","LU1037948897.HKD","LU1989772923.USD","BK4550","LU0689626769.HKD","LU0203345920.USD","SG9999014542.SGD","LU0965509101.SGD","IHF","LU2491050154.USD","BK4533","LU1201861249.SGD","LU0130102774.USD","IE00B2B36J28.USD","LU0433182093.SGD","LU2244417387.USD","LU2324357040.USD","LU1116320737.USD","LU1291159041.SGD","LU1061106388.HKD","SG9999014005.SGD","SG9999014575.USD","LU0058720904.USD","LU0106261372.USD","LU0985320562.USD","BK4559","IE00BN8TJ469.HKD","LU0208291251.USD","LU1057294990.SGD","LU0068578508.USD","LU0238689110.USD","IE000M9KFDE8.USD","LU0128525929.USD","HRTS","LU2468319806.SGD","IE00B775SV38.USD","LU0708994859.HKD","LU0130517989.USD","LU1069347547.HKD","HCA","SG9999001176.USD","BK4185","LU1023059063.AUD","LU0211328371.USD","FTXH","SG9999014039.USD","SG9999002224.SGD","LU1974910355.USD","LU0823416689.USD","BK4534","LU0648001328.SGD","LU1084165304.USD","LU2023250843.SGD","IE00BJT1NW94.SGD","LU0114720955.EUR","IE00BLSP4452.SGD","LU1066051498.USD","LU0868494617.USD","LU2433249047.HKD","SG9999001176.SGD","IYH","LU2106854487.HKD","LU0122379950.USD","IHE","LU0320765646.SGD","LU2125154778.USD","VHT","LU1983299246.USD","BK4504","LU2360032135.SGD","LU0320765489.SGD","LU0070302665.USD","LU1116320901.HKD","LU0985489474.SGD","IE00BSNM7G36.USD","LU0942090050.USD","LU1093756168.USD","SG9999014021.USD","LU1585245621.USD","LU0310800379.SGD","LU0266013472.USD","LU1917777945.USD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659526441","title":"Atrium Gets $15M in Latest Milestone Payment from Bristol Myers Squibb","url":"https://stock-news.laohu8.com/highlight/detail?id=2659526441","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659526441?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:39","pubTimestamp":1786624740,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics earned another $15 million milestone payment from Bristol Myers Squibb based on the successful delivery of a compound targeting an undisclosed cardiology indication.The payment is pursuant to Atrium's global licensing-and-research partnership with BMS, the biopharmaceutical company, which focuses on RNA therapies for the heart, said Thursday.Under the terms of the agreement, Atrium is eligible to receive up to $1.35 billion in research-and-development milestones payments, as well as up to $825 million in commercial milestone payments.It is also eligible for royalties of up to a low double-digit percentage of net sales. BMS will fund all future clinical development, regulatory and commercial activities coming from the collaboration.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Atrium Gets $15M in Latest Milestone Payment from Bristol Myers Squibb","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","IE0002141913.USD","BK4532","LU1291159041.SGD","LU0267386448.USD","LU1868836757.USD","LU1571399168.USD","LU1074936037.SGD","LU2242652126.USD","LU0432979614.USD","BK4585","LU0321505868.SGD","LU2125154778.USD","LU1868836914.USD","LU2360032135.SGD","BK4581","LU0096364046.USD","LU1670711040.USD","LU2242646821.SGD","LU1670710588.SGD","LU1670711123.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU1983299246.USD","BK4007","LU1032466523.USD","LU1868836591.USD","IE00BJT1NW94.SGD","LU1868837300.USD","LU2133065610.SGD","LU2596442595.SGD","LU1868837136.USD","FTXH","LU0868494617.USD","LU1718418525.SGD","LU0225284248.USD","IE00BFXG1179.USD","BMY","LU0306806265.USD","LU0306807586.USD","LU0114720955.EUR","LU0061475181.USD","LU0985481810.HKD","BK4588","IE00B2B36J28.USD","LU1585245621.USD","LU0456855351.SGD","IHE","LU1430594728.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659512891","title":"Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2659512891","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659512891?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622411,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA53QBVJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1989771016.USD","BK4139","LU0237698245.USD","BK4581","LU1093756168.USD","LU2133065610.SGD","IE0002141913.USD","IHE","LU0225284248.USD","LU0432979614.USD","LU1291159041.SGD","LU1430594728.SGD","LU0306806265.USD","LU1883839398.USD","LU1670711040.USD","LU1670710588.SGD","BK4534","LU1868837136.USD","IE0009355771.USD","BK4559","IE00BSNM7G36.USD","FTXH","IE00BFXG1179.USD","LU1983299246.USD","LU1868837300.USD","LU2125154778.USD","LU1571399168.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2242652126.USD","LU1718418525.SGD","LU1868836757.USD","BK4532","LU0114720955.EUR","LU1868836914.USD","LU0882574055.USD","LU2125154935.USD","LU0456855351.SGD","LU0225771236.USD","BMY","IE00BFTCPJ56.SGD","RNA","LU0321505439.SGD","LU1670710661.SGD","BK4007","LU0306807586.USD","LU1032466523.USD","LU2360032135.SGD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151265","title":"Atrium Therapeutics - Eligible for up to $1.35 Bln R&D Milestones, $825 Mln Commercial Milestones, Tiered Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151265?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622411,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA53QBVJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1883839398.USD","LU1571399168.USD","LU1670711123.USD","IE0002141913.USD","LU1430594728.SGD","LU0225284248.USD","LU1670710661.SGD","BK4588","LU1868836591.USD","LU0868494617.USD","LU2125154935.USD","LU1074936037.SGD","LU0061475181.USD","LU0306807586.USD","LU1670711040.USD","LU1718418525.SGD","LU0985481810.HKD","IE00BSNM7G36.USD","BK4532","BK4585","IE0009354923.USD","LU2133065610.SGD","LU2596442595.SGD","LU0321505868.SGD","BMY","LU0237698245.USD","FTXH","BK4534","LU1868836914.USD","IE00BFXG1179.USD","LU1983299246.USD","LU2242652126.USD","IE00BJT1NW94.SGD","RNA","LU0432979614.USD","LU0456855351.SGD","LU0321505439.SGD","LU1989771016.USD","LU2242646821.SGD","LU2360032135.SGD","IHE","IE00BJJMRZ35.SGD","LU0225771236.USD","LU2125154778.USD","LU1261432733.SGD","LU1291159041.SGD","BK4505","LU1093756325.SGD","LU0267386448.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151218","title":"Atrium Therapeutics - Bristol Myers Squibb to Fund All Future Development and Commercialization Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151218?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:00","pubTimestamp":1786622411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA53QBVJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMY","IE0009354923.USD","BK4532","LU0456855351.SGD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0267386448.USD","LU1868836591.USD","LU2125154778.USD","LU0225284248.USD","LU0096364046.USD","BK4588","LU1430594728.SGD","IE00BJT1NW94.SGD","LU0321505868.SGD","BK4007","LU1868837136.USD","LU0432979614.USD","LU1718418525.SGD","LU1074936037.SGD","LU0306806265.USD","LU1032466523.USD","LU1093756325.SGD","LU1868836914.USD","IE00B2B36J28.USD","LU1670711040.USD","LU0882574055.USD","LU0985481810.HKD","BK4581","LU1585245621.USD","BK4585","FTXH","LU1868836757.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU2242652126.USD","LU2360032135.SGD","LU1868837300.USD","LU0114720955.EUR","LU0306807586.USD","LU2596442595.SGD","LU0868494617.USD","RNA","LU1291159041.SGD","LU1670710588.SGD","IHE","LU1983299246.USD","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659515818","title":"Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2659515818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659515818?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615200,"startTime":"0","endTime":"0","summary":"Novo CEO says obesity market won't be winner-take-all battle with LillyNEW YORK, Aug 13 (Reuters)-Novo NordiskNOVOb.COCEO Mike Doustdar said investors are underestimating the demand for differentiatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N4490UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2461242641.AUD","SG9999017495.SGD","WDNA","LLY","LU0354030511.USD","SG9999014898.SGD","BK4534","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU0689472784.USD","LU2471134952.CNY","LU1868836591.USD","LU2168564149.EUR","BK4588","LU0353189763.USD","LU0471298777.SGD","LU0203201768.USD","LU0466842654.USD","LU2468319806.SGD","LU2361045086.USD","LU2462157665.USD","IE00BKVL7J92.USD","LU0234572021.USD","LU1093756168.USD","LU1989771016.USD","BK4599","LU2028103732.USD","HRTS","LU0079474960.USD","SG9999013999.USD","IE00BN29S564.USD","LU2237443978.SGD","LU0266013472.USD","LLYZ","OZEM","XLV","LU2237443622.USD","JDOC","AGNG","LU1093756325.SGD","LU2456880835.USD","LU1280957306.USD","LU1323610961.USD","CURE","LU2746668974.SGD","LU2750360997.AUD","LU0225283273.USD","IE00BFSS8Q28.SGD","LU2023251221.USD","MEDX","LU2237438978.USD","LU2168563687.JPY","VHT","ELIS","LU2236285917.USD","BK4516","LU0943347566.SGD","IE0004445239.USD","LU0006306889.USD","LU1720051017.SGD","THNR","SGXZ31699556.SGD","LU0198837287.USD","LU0203202063.USD","LU2089984988.USD","IE00B1BXHZ80.USD","LU1069344957.HKD","LU0708995401.HKD","LU1551013425.SGD","LU2111349929.HKD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","FHLC","LU0316494557.USD","LU2112291526.USD","IE00B1XK9C88.USD","IE00BKDWB100.SGD","LU0889565916.HKD","LU1974910355.USD","IE00BJT1NW94.SGD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0323591593.USD","PPH","LU1366192091.USD","LLYX","LU2552382132.HKD","PJP","LU2168564065.EUR","LU0964807845.USD","LU2023250330.USD","LU2264538146.SGD","LU1623119135.USD","LU2213496289.HKD","SG9999015952.SGD","IE00BK4W5L77.USD","IE00B775H168.HKD","LU0109394709.USD","LU2417539215.USD","IXJ","LU0256863811.USD","LU2471134523.USD","LU2750360641.GBP","LU0158827781.USD","LU1145028129.USD","LU0345770308.USD","NVOX","LU0353189680.USD","LU0882574055.USD","LU1061106388.HKD","LU0672654240.SGD","LU0320765992.SGD","GB00BDT5M118.USD","LU2756315318.SGD","MEDI","LU1064131342.USD","FTXH","LU1868836757.USD","LU0786609619.USD","LU1868837300.USD","LU0114720955.EUR","LU2237443549.SGD","LU2324357040.USD","LU1291159041.SGD","LU1720051108.HKD","LU2491049909.HKD","LU2089284900.SGD","LU1804176565.USD","LU0106261372.USD","LU0094547139.USD","LU2168564495.EUR","LU0122379950.USD","BK4533","SG9999015978.USD","LU0823434583.USD","LU0109391861.USD","LU1267930730.SGD","SGXZ51526630.SGD","LU0823416689.USD","IE0009355771.USD","IE00BK4W5M84.HKD","SG9999018857.SGD","LU1917777945.USD","SGXZ99366536.SGD","LU2471134796.USD","LU0289739699.SGD","LU2896262040.SGD","LU0096364046.USD","LU0882574139.USD","IE00B7KXQ091.USD","IE0005OL40V9.USD","LU1629891620.HKD","LU2106854487.HKD","LU2063271972.USD","MHIP","IYH","BK4007","LLII","IE00BJLML261.HKD","LU2746668461.USD","SGXZ57979304.SGD","LU0354030438.USD","SG9999018865.SGD","LU2360106947.USD","LU1548497426.USD","LU2089283258.USD","LU0238689110.USD","LU0683600562.USD","LU0787776722.HKD","LU2271345857.HKD","LU2237443465.HKD","LU0820562030.AUD","LU1868836914.USD","LU2491050071.SGD","LU2552382058.USD","SG9999001176.SGD","SG9999014906.USD","LU0058720904.USD","LU2602419157.SGD","LU2361044949.HKD","CANC","LU1979441026.SGD","LU2552382215.SGD","LU2462591350.SGD","BK4581","LU2087625088.SGD","SG9999014880.SGD","LU2237443382.USD","LU0133085943.USD","RXL","TMED","IE00B4JS1V06.HKD","LU1232071149.USD","LU2361044865.SGD","LU0158827948.USD","LU2108987350.USD","GDOC","LU2023250504.SGD","SG9999001176.USD","IE0002141913.USD","LU0417517546.SGD","SG9999014914.USD","LU0320765059.SGD","LU1127390331.HKD","LU2237443895.HKD","LU2756315664.SGD","BK4532","LU0820561909.HKD","LU1551013342.USD","LU0456855351.SGD","LU0097036916.USD","LU2491050154.USD","ELIL","LU1814569148.SGD","IE00BKPKM429.USD","NVOH","SGXZ81514606.USD","LU0471298694.HKD","LU0061475181.USD","LU0256863902.USD","SG9999015986.USD","NVO","IE00B4R5TH58.HKD","LU0385154629.USD","LU1868837136.USD","LU0345770993.USD","LU2211815571.USD","LU0432979614.USD","LU2168564222.USD","LU0174119429.USD","TRUH","LU0154236417.USD","LU1712237335.SGD","IE0004445015.USD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","LU1023059063.AUD","LU0210536198.USD","LU2265009873.SGD","IE00BWXC8680.SGD","LU0640476718.USD","IE00BJJMRX11.SGD","LU0820561818.USD","BK4585","LU1035775433.USD","LU1988902786.USD","LU2357305700.SGD","ILDR","SG9999015945.SGD","IHE","LU1983299246.USD","LU2471134879.HKD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":12,"totalSize":271,"code":"91000000","status":"200"}]}}